Bloomberg reports that Gome Electrical Appliances Holdings Ltd. may sell up to 20% of the company to Bain Capital. The asking price is said to be in the neighborhood of $500 million. KKR & Co. and Warburg Pincus are also said to be interested in the stake in Gome.

With more than 800 stores in 160 cities, Gome is China's second-largest electronics retailer, which makes it a tempting target for investors looking for alternatives to recession-constrained businesses in the United States, Europe, and developed markets in Asia.

Most private equity firms hunt for stable companies with stable cash flows that are either cheap or inefficiently operated. These companies can then be resold for more money or taken public, or the strategy can fit into the Warren Buffett time frame of "forever." Biotechnology has long been the realm for only public companies, but that is changing.

Private equity firm Warburg Pincus has already made some biotech plays that seemed to be a harbinger of the trends here, and even more so when you consider foreign drug companies buying US-based biotechs on the cheap with that US Peso of a currency we have.

A new fund called GANIC Pharmaceuticals has been launched this week, with Warburg Pincus as the main backer. the private equity firm made an initial investment in GANIC from the Warburg Pincus Private Equity X, L.P., a $15 billion fund which closed in April. As of now, we do not have any exact launch figures for the size of the investment that was given to GANIC.

GANIC's management is all former senior executives of MedPointe Pharmaceuticals and the company will will focus on building a substantial enterprise by acquiring revenue generating companies, portfolios, and/or products and by investing in innovation and acquiring pipeline development assets.

Read more at BioHealthInvestor.com for estimates of the size and strategies that the fund may employ.

Warburg Pincus has recently announced the closing of a $15 billion global private equity fund, Warburg Pincus Private Equity X. Many existing investors increased funds to WP X and includes various investors such as public and private pension funds, endowments, and global financial institutions such as Washington State Investment Board and GE Asset Management.

Warburg Pincus currently manages over $35 billion in assets globally. The global fund will focus on businesses in any growth stage in core industries in North America, Europe, and Asia. The company invests across geographies, industries, and business growth stages from a single global fund, always with a focus on growing businesses and growing regions.

They have significant experience in consumer and retail, energy, financial services, healthcare, life sciences, industrial, technology, media and telecommunications. Typically, Warburg provides funding for the creation of business or to expand them where long run growth and sustainability is a central factor.

While this is backward looking, private equity generated fees for Wall Street are plummeting. That will continue as long as the situation remains here and as long as the de-leveraging trends continue. Try to find someone who thinks this won't continue for at least a while longer.

Revenue generation on Wall Street from private equity fees has significantly slowed this year. Blame the credit crunch and decline in deal volume, but either way the de-leveraging on Wall Street is taking its toll. CNN Money has a summary describing this from LBO Wire.

The top fee-generating firms on Wall Street are Credit Suisse Group (NYSE: CS), Citigroup Inc. (NYSE: C), J.P. Morgan Chase & Co. (NYSE: JPM), Goldman Sachs Group (NYSE: GS) and Lehman Brothers Holdings Inc. (NYSE: LEH).

According to Dealogic, fees are down 75% from last year, from roughly $3.7 billion in first quarter 2007 to about $895 million in 2008. The share of fees to investment banks currently sits at about 10% of revenues, down from about 23% of total revenues this time last year. While leveraged buyouts in the U.S. have slowed, the two most active buyout shops this year, Apollo Advisors and TPG Capital, have paid over $200 million in total fees to banks this year. Ranking behind them are Warburg Pincus, Alfa Capital Partners, and the Carlyle Group.

There are still a lot of good things happening at private equity firms:

• You think buyouts are dead? Bain Capital just closed on a $20 billion fund raising for another global buyout fund.
• Invesco also just closed on a $4 Billion distressed fund.
• The Midwest Air Group (AMEX: MEH) is set to close today after all approvals have been met. TPG Capital is the acquirer.

There is still activity going on in pending deals and the earnings releases:

• MBIA Inc. (NYSE: MBI) is lucky. Even after their dismal earnings it still got funded at much higher prices than the current market prices.
• Alliance Data Systems Corp. (NYSE: ADS) received numerous upgrades after beating earnings last night, and that is after suing Blackstone Group (NYSE: BX) over the likely failed merger. What a rally!
  

As far as public investing and private equity in IPO's, there is more:

• SeaCastle Inc. has pulled its IPO due to market conditions. This one was supposed to be a $2.2 Billion company after the IPO, and Fortress Investment Group owns almost the entire company.
• After earnings today, Procter & Gamble Co. (NYSE: PG) confirmed that it is spinning off its Folgers Coffee Company operations.

Interesting trading activities abound:

• A hedge fund has sent notice to Countrywide Financial Corp. (NYSE: CFC) that it is selling too cheap and it aims to make the firm seek a higher price. I bet this fund loves Doug McIntyre's "Make Mozillo Take The Bonus" piece.
  
• We have noted some scared traders worrying about Clear Channel Communications (NYSE: CCU) on whether or not its buyout was coming. Yesterday we saw 32,315 options contracts trade in the April-2008 $30 Call options, which is 3.2 million shares on a fully leveraged basis.

This is interesting and definitely worth a quick read. DealBook, from The New York Times, asks "Could M&A Help Save The Economy?"

Jon Ogg is an editor of 247WallSt.com.

Shares of MBIA Inc. (NYSE: MBI) soared almost 30% after the world's largest bond insurer got a $1 billion cash infusion from Warburg Pincus LLC, a private equity firm.

The money couldn't have come at a better time for Armonk, N.Y.-based MBIA, which faced a potentially crippling downgrade from the credit rating agencies As Bloomberg News notes, "MBIA's AAA ranking stands behind $652 billion of state, municipal and structured finance bonds, and losing the AAA credit rating would endanger MBIA's ability to guarantee debt, its main source of revenue."

Under the terms of the agreement, Warburg Pincus will make an initial investment of $500 million through the acquisition of 16.1 million shares at $31 per share, a slight premium over Friday's closing. The investor will also backstop a shareholder rights offering of up to $500 million that MBIA expects to make next year. In addition, Warburg will receive warrants to purchase 8.7 million shares of MBIA common stock at a price of $40, and "B" warrants, which, upon obtaining certain approvals, will become exercisable to purchase 7.4 million shares of stock at $40.

Bausch & Lomb (NYSE: BOL) -- volatility of 11 at low end of Range. BOL closed at $62.54. BOL announced it would be purchased by Warburg Pincus for $65 in cash on 5/16/07. Advanced Medical Optics Inc. (NYSE: EYE) announced yesterday it withdrew its offer to purchase BOL for $75. BOL over all option implied volatility is at 11 according to Track Data, suggests decreasing risk.

CheckFree (NASDAQ: CKFR) -- volatility Elevated prior to Fiserve Inc. (NYSE: FISV) paying $4.4 billion for CKFR. CKFR, an online banking, electronic payments, and financials infrastructure and services company, will be purchased by FISV for $48 a share in cash. CKFR will report EPS on August 9th. CKFR over all option implied volatility of 41 was above its 26-week average of 33 according to Track Data, suggesting larger risk.

Accredited Home Lenders (NASDAQ: LEND) -- volatility Spikes higher on Credit concerns. LEND, a mortgage company originating, financing, securitizing, servicing and selling non-prime mortgages, is recently down $2.14 to $6.07. Dow Jones said, "LEND on Thursday filed its delayed 2006 annual report, and raised concerns about its ability to continue to operate as a going concern." Lone Star announced on 6/4/07 it would acquire all of LEND's common stock for roughly $15 per share in cash. LEND September option implied volatility is above 225 according to Track Data, suggesting larger risk.

Daily M&A Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Bausch & Lomb (NYSE BOL)'s vision of going private has grown cloudy.

Back in mid-May, the eye-care products maker agreed to a $3.67 billion buyout offer from private equity firm Warburg Pincus. But on Thursday, a group of Bausch & Lomb directors met to discuss a bid from competitor Advanced Medical Optics (NYSE: EYE); AMO's bid raised Warburg Pincus' $65/share bid by a value of $10 a share -- $45 in cash and $30 in shares of Advanced Medical.

Warburg Pincus' offer had given Bausch & Lomb until Thursday to consider counter-bids.

Shareholders seemed unimpressed by B&L's reported openness to Advanced Medical's bid, which faces at least one regulatory snag -- both companies are leading makers of content lens solution. AMO's shares slipped 4 cents to $35.85 Friday; Bausch & Lomb shares eked out a half-penny rise to finish the week at $72.

The California-based Advanced Medical Optics bid alone, but has spoken to KKR and Goldman Sachs Group, along with AMO shareholder ValueAct Capital, about partnering on the proposed purchase.

Warburg Pincus has a long history of financing turnarounds in the health care industry; past holdings include United Healthcare, American Medical Systems (NASDAQ: AMMD), managed care provider Coventry, Oxford Glycosciences, and Zentiva (LSE: ZEND).

Could Advanced Medical Optics reverse Bausch & Lomb's late decline -- product recalls, stymied financial reporting? Will Warburg answer AMO's bid? It remains to be seen.

Bausch & Lomb Inc. (NYSE: BOL) needed a savior, and today it announced it had found one in private equity firm Warburg Pincus, which agreed to buy the troubled eyecare products company for $3.67 billion. It's a match that makes eminent sense: Warburg Pincus is the long-acknowledged master of health care finance, skilled at using its heft in the industry to orchestrate turnarounds of the small and mega varieties. Bausch & Lomb is plagued by product recalls which have delayed financial reporting and caused a major hit to the brand's reliability. What once was seen as a premium brand has fallen significantly in the eyes of the consumer -- and management hasn't yet shown any nimbleness in addressing its brand and accounting issues.

The purchase price, about $67.40 a share (Warburg Pincus will also assume $830 million of the company's debt), is only a small premium to the current price, and already the stock is up $5.75, or 9.3%, to $67.25 on the news. Analysts agree that the deal seems fair, and that going private for a bit makes sense for Bausch & Lomb -- it's not easy dealing with such huge issues in the public eye.

Meanwhile, members of the health care group at Warburg Pincus must be salivating for the chance to do every PE employee's favorite task: get strategical and really fix something.

According to a story in Women's Wear Daily, it looks like Neiman Marcus' private equity owners -- Texas Pacific Group (TPG) and Warburg Pincus -- are considering an IPO of the firm. They bought out the company back in 2005.

The IPO could come as early as this summer, although it's more likely to be early next year.

Neiman Marcus has been posting strong results lately. In the fiscal second quarter, sales increased 8.5% to $1.3 billion and operating earnings spiked from $69.7 million to $127.8 million. The company plans to expand the number of its stores to 50-52 by 2010, up from 44. Neiman has also been building out clearance centers, called Last Call.

There has been a drought in retail IPOs. But in light of TPG's highly successful IPO of J. Crew (NYSE: JCG), there's likely to be some interest in a Neiman Marcus offering.

Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.